Matching trials
1,853 results
- SUPERNOVAIndependent statistical analysis of the randomized phase 2/3 SUPERNOVA trial of AZD3152 and AZD7442 for prevention of COVID-19, including non-inferiority, superiority, Poisson regression, ANOVA, safety, and interpretation of reported results.
- SURMOUNT-3Independent statistical analysis of the phase 3 SURMOUNT-3 trial of tirzepatide in participants with obesity or overweight after a lifestyle weight loss program, including trial design, primary endpoints, reported estimates, statistical methods,…
- SURMOUNT-CNIndependent statistical analysis of A Study of Tirzepatide (LY3298176) in Chinese Participants Without Type 2 Diabetes Who Have Obesity or Overweight (SURMOUNT-CN): primary endpoint results, effect estimate with confidence interval, sample-size planning…
- SURMOUNT-MMOIndependent statistical analysis of SURMOUNT-MMO, a randomized phase 3 study of tirzepatide versus placebo in adults with obesity or overweight, including its composite time-to-event endpoint, design, planned analysis, and statistical interpretation.
- SURMOUNT-OSAIndependent statistical analysis of SURMOUNT-OSA, a randomized phase 3 trial of tirzepatide in participants with obstructive sleep apnea and obesity, including AHI results, ANCOVA, logistic regression, confidence intervals, and safety.
- SURPASSIndependent statistical analysis of Effect of Secukinumab on Radiographic Progression in Ankylosing Spondylitis as Compared to GP2017 (Adalimumab Biosimilar): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- SURPASS-4Independent statistical analysis of SURPASS-4, a randomized phase 3 trial of once-weekly tirzepatide versus once-daily insulin glargine in participants with type 2 diabetes and increased cardiovascular risk.
- SURPASS-6Independent statistical analysis of A Study of Tirzepatide (LY3298176) Versus Insulin Lispro (U100) in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine (U100) With or Without Metformin: primary endpoint results,…
- SURTIMEIndependent statistical analysis of the SURTIME phase 3 trial of immediate surgery or surgery after sunitinib malate in metastatic kidney cancer, including trial design, progression-free survival, planned analysis, statistical interpretation, and limitations.
- SUSTAINIndependent statistical analysis of Efficacy and Safety of Semaglutide Once-weekly Versus Sitagliptin Once-daily as add-on to Metformin in Subjects With Type 2 Diabetes (SUSTAIN - CHINA MRCT): primary endpoint results, effect estimate…
- SUSTAIN 11Complete statistical analysis of SUSTAIN 11, a randomized phase 3 trial comparing semaglutide with insulin aspart when added to metformin and insulin glargine in people with type 2 diabetes.
- SUSTAIN-7Independent statistical analysis of the SUSTAIN-7 phase 3 trial comparing semaglutide with dulaglutide as add-on to metformin in subjects with type 2 diabetes, including mixed-effects modeling, non-inferiority and superiority testing, confidence intervals,…
- SUSTAIN™ 2Complete statistical analysis of SUSTAIN™ 2, a randomized phase 3 trial comparing once-weekly semaglutide with once-daily sitagliptin as add-on therapy in subjects with type 2 diabetes.
- SUSTAIN™ 5Independent statistical analysis of Efficacy and Safety of Semaglutide Once-weekly Versus Placebo as add-on to Basal Insulin Alone or Basal Insulin in Combination With Metformin in Subjects With Type 2 Diabetes: primary…
- SVIComplete statistical analysis of the randomized phase 3 SVI trial comparing indomethacin alone with indomethacin plus prophylactic pancreatic stent placement for preventing post-ERCP pancreatitis.
- SWIFT-1Independent statistical analysis of Placebo-controlled Efficacy and Safety Study of GSK3511294 (Depemokimab) in Participants With Severe Asthma With an Eosinophilic Phenotype: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- SWITCH 2Independent statistical analysis of A Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, With or Without OADs in Subjects With Type 2 Diabetes: primary endpoint results, effect estimate…
- SWOG 9346Independent statistical analysis of SWOG 9346, a randomized phase 3 trial of intermittent versus continuous hormonal therapy in men with stage IV prostate cancer, including overall survival and 3-month functional outcomes.
- SYGMA2Complete statistical analysis of SYGMA2, a randomized phase 3 trial evaluating as-needed budesonide/formoterol versus twice-daily budesonide with as-needed terbutaline in adults and adolescents with asthma.
- SYMPHONYextIndependent statistical analysis of Clinical Study of Macitentan in Patients With PAH to Psychometrically Validate PAH-SYMPACT Instrument: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Synagis RussiaIndependent statistical analysis of A Study to Assess the Safety and Effectiveness of Palivizumab Administered to Children at High Risk of Severe Respiratory Syncytial Virus (RSV) Infection in the Russian Federation and…
- TACTiCComplete statistical analysis of the TACTiC phase 3 trial of 5 mg rosuvastatin calcium with a Web App in consumers with high cholesterol, including endpoint definitions, reported estimates, confidence intervals, statistical methodology,…
- TAILORIndependent statistical analysis of the TAILOR phase 3 trial evaluating erlotinib versus docetaxel in non small cell lung cancer, including trial design, endpoints, planned statistical methods, and interpretation.
- TALCIndependent statistical analysis of Asthma Clinical Research Network (ACRN) Trial - Tiotropium Bromide as an Alternative to Increased Inhaled Corticosteroid in Patients Inadequately Controlled on a Lower Dose of Inhaled Corticosteroid (TALC):…
- TANGOIndependent statistical analysis of A Phase 3 Study of Tanezumab for Chronic Low Back Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- TANGOIndependent statistical analysis of CER-001 Therapy as a Novel Approach to Treat Genetic Orphan Diseases: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- TARDISIndependent statistical analysis of the TARDIS phase 3 trial evaluating triple antiplatelet therapy after ischaemic stroke, including design, endpoints, planned analysis, methodology, and interpretation.
- TAX316Complete statistical analysis of TAX316, a randomized phase 3 trial comparing docetaxel-containing TAC with FAC in node-positive adjuvant breast cancer, including disease-free survival, overall survival, statistical methodology, safety, and interpretation.
- TAZPOWERIndependent statistical analysis of A Trial to Evaluate Safety, Tolerability and Efficacy of Elamipretide in Subjects With Barth Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- TBTC Study 22An independent statistical analysis and educational interpretation of TBTC Study 22, a randomized phase 3 trial evaluating rifapentine and isoniazid in pulmonary tuberculosis.
- TEAMIndependent statistical analysis of TEAM, the randomized phase 3 trial comparing exemestane with tamoxifen followed by exemestane in postmenopausal patients with receptor-positive breast cancer. Includes disease-free survival, overall survival, time to relapse,…
- TeenCoveComplete statistical analysis of the TeenCove trial of mRNA-1273 and mRNA-1273.222 in adolescents 12 to
- TEMPO-2Complete statistical analysis of TEMPO-2, a randomized phase 3 trial of tenecteplase versus antiplatelet treatment for minor acute ischemic stroke with proven occlusion, including trial design, the 90-day modified Rankin Scale endpoint,…
- TEMPO3:4Complete statistical analysis of the TEMPO3:4 phase 3 trial of tolvaptan versus placebo in autosomal dominant polycystic kidney disease, including trial design, endpoints, mixed-effects modeling, recurrent-event analysis, ANCOVA, and reported results.
- TEMPRANOAn independent statistical analysis of the phase 3 TEMPRANO trial, evaluating early antiretroviral treatment and/or early isoniazid prophylaxis against tuberculosis in HIV-infected adults.
- TERIKIDSIndependent statistical analysis of Efficacy, Safety and Pharmacokinetics of Teriflunomide in Pediatric Patients With Relapsing Forms of Multiple Sclerosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- TEXTIndependent statistical analysis of TEXT, a randomized phase 3 trial of triptorelin with either exemestane or tamoxifen in premenopausal women with hormone-responsive breast cancer, including time-to-event endpoints, hazard ratios, confidence intervals, log-rank…
- THALESComplete statistical analysis of the phase 3 THALES trial of ticagrelor versus placebo in acute ischaemic stroke and transient ischaemic attack, including trial design, endpoints, Cox and logistic regression methods, efficacy results,…
- THORIndependent statistical analysis of A Study of Erdafitinib Compared With Vinflunine or Docetaxel or Pembrolizumab in Participants With Advanced Urothelial Cancer and Selected Fibroblast Growth Factor Receptor (FGFR) Gene Aberrations: primary endpoint…
- TIM-HF2Independent statistical analysis of TIM-HF2, a randomized phase 3 trial evaluating Remote Patient Management versus usual care in chronic heart failure. Includes trial design, endpoints, planned analysis, and statistical interpretation.
- TIRCON-EXTIndependent statistical analysis of Long-term Deferiprone Treatment in Patients With Pantothenate Kinase-Associated Neurodegeneration: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02174848).
- TITREIndependent statistical analysis of Influenza Vaccine Dose-Response in Infants and Toddlers: Immunogenicity and Reactogenicity: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00710866).
- TIVO-1An independent statistical analysis of the phase 3 TIVO-1 trial comparing tivozanib with sorafenib in subjects with advanced renal cell carcinoma, including trial design, the registered progression-free survival endpoint, planned statistical analysis,…
- TIVO-1Independent statistical analysis of A Study to Compare Tivozanib (AV-951) to Sorafenib in Subjects With Advanced Renal Cell Carcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- TK008Independent statistical analysis of Efficacy Study on the Strategy of HSV-Tk Engineering Donor Lymphocytes to Treat Patients With High Risk Acute Leukemia: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- TN07Independent statistical analysis of Oral Insulin for Prevention of Diabetes in Relatives at Risk for Type 1 Diabetes Mellitus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- TNTIndependent statistical analysis of the phase 3 TNT trial of carboplatin and docetaxel in breast cancer, including its crossover design, response endpoint, planned analysis, and statistical interpretation.
- TOBRAIndependent statistical analysis of the randomized phase 3 TOBRA trial evaluating local vancomycin versus local vancomycin plus tobramycin powders to reduce deep surgical site infection after definitive fracture fixation.
- TOPAZ-1Independent statistical analysis of Durvalumab or Placebo in Combination With Gemcitabine/Cisplatin in Patients With 1st Line Advanced Biliary Tract Cancer (TOPAZ-1): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- TOPAZ-IIndependent statistical analysis of A Study to Evaluate Long-term Outcomes Following Treatment With ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 With or Without Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV)…